Related Experiment Video
Updated: Jun 29, 2026

Using Real-Time Cell Metabolic Flux Analyzer to Monitor Osteoblast Bioenergetics
Published on: March 1, 2022
[Experimental advances in mineral metabolism]
1Laboratorio de Investigacion, Hospital Universitario Arnau de Vilanova, IRBLLEIDA, Lleida, Spain.
Insights
Hyperphosphatemia is a major contributor to cardiovascular mortality in dialysis patients. Recent research focuses on novel methods to control phosphate absorption, kidney elimination, and vascular calcification in chronic kidney disease.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Biochemistry
Background:
- Cardiovascular disease is a leading cause of mortality in patients undergoing dialysis.
- Hyperphosphatemia is a significant contributing factor to cardiovascular complications in this population.
- There is an ongoing effort to lower target serum phosphate levels in chronic kidney disease (CKD) patients.
Purpose of the Study:
- To review recent advancements in managing hyperphosphatemia in CKD patients.
- To highlight novel strategies for controlling phosphate absorption and renal excretion.
- To discuss the latest findings on vascular calcification as a consequence of hyperphosphatemia.
Main Methods:
- Literature review of studies published within the last year.
- Focus on basic research related to phosphate metabolism and vascular health.
- Analysis of methods for phosphate absorption control, renal elimination, and prevention of vascular calcification.
Main Results:
- Emerging strategies for managing phosphate absorption are being explored.
- New insights into the mechanisms of phosphate elimination by the kidneys have been presented.
- Recent research has shed light on the progression and prevention of vascular calcifications.
Conclusions:
- Effective phosphate control remains a critical challenge in nephrology.
- Novel therapeutic approaches are needed to mitigate cardiovascular risks associated with hyperphosphatemia.
- Further research is essential to address the complex interplay between phosphate, kidney function, and cardiovascular health.
Abstract:
One of the most important problems faced by nephrologists is the high degree of cardiovascular mortality in patients on dialysis. This increase in cardiovascular disease has been associated with various factors, but, among them, hyperphosphatemia stands out particularly. The serum phosphate levels considered normal in these patients have gradually decreased in recent years. Therefore, phosphate control in the chronic kidney disease patient has become a challenge that has stimulated basic research in recent years. The aim of the following review is to bring together the most novel results presented in the last year, with emphasis on the methods for control of phosphate absorption, its elimination by the kidneys and vascular calcifications, which are one of the most serious direct consequences of hyperphosphatemia.
More Related Videos
Related Concept Videos
Minerals
Mineral, Vitamin and Water Absorption
Metabolism of Chemolithotrophs
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Regulation of Metabolism
Metabolic States of the Body: The Absorptive State

